comparemela.com

Latest Breaking News On - Chris wack - Page 5 : comparemela.com

Deciphera Pharmaceuticals Gets $2.4 Billion Buyout Offer From ONO Pharmaceutical

By Chris Wack Deciphera Pharmaceuticals is being bought by ONO Pharmaceutical for $25.60 a share in cash through a tender offer with a total equity value of $2.4 billion. Deciphera shares.

Chris-wack
Deciphera-pharmaceuticals
Dow-jones
Markets

X4 Pharmaceuticals Gets FDA Approval for Xolremdi Capsules

By Chris Wack X4 Pharmaceuticals said that the Food and Drug Administration approved Xolremdi capsules for use in patients 12 years of age and older with WHIM syndrome to increase the number.

Chris-wack
Drug-administration
Breakthrough-therapy-designation
New-drug-application
Priority-review
Rare-pediatric-disease-priority-review-voucher
Dow-jones

Meta's Oversight Board Prepares for Layoffs, Washington Post Reports

Meta s company-funded oversight body is planning to trim its workforce, a downsizing effort that could affect the board s ability to police the world s largest social media network, the.

Washington
United-states
Chris-wack
Washington-post
Oversight-board
Dow-jones
Markets

Deciphera Shares Hit 2-Year High After $2.4 Billion Buyout Offer From ONO Pharma

By Chris Wack Deciphera Pharmaceuticals shares hit a two-year high after receiving a buyout offer from ONO Pharmaceutical for $25.60 a share in cash, through a tender offer with a total equity.

Chris-wack
Deciphera-pharmaceuticals
Dow-jones
Markets

Soleno Therapeutics Gets Breakthrough Therapy Designation for Diazoxide Choline

By Chris Wack Soleno Therapeutics said that the Food and Drug Administration has granted Breakthrough Therapy Designation for diazoxide choline extended-release tablets for the treatment.

Chris-wack
Drug-administration
Breakthrough-therapy-designation
New-drug-application
Therapy-designation
Orphan-drug-designation
Fast-track-designation
Dow-jones
Markets

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.